Haiyang Chen Selected Research

Haiyang Chen Research Topics

Disease

15	Neoplasms (Cancer) 05/2024 - 01/2015
9	Inflammation (Inflammations) 04/2024 - 11/2014
6	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 04/2012
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 11/2016
5	Rectal Neoplasms (Rectal Cancer) 01/2022 - 01/2019
4	Neoplasm Metastasis (Metastasis) 01/2023 - 06/2013
3	Lung Neoplasms (Lung Cancer) 04/2024 - 10/2017
3	Carcinogenesis 01/2015 - 04/2012
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2024 - 01/2023
2	Disease Progression 04/2024 - 04/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 11/2021
2	Lung Injury 12/2023 - 12/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 01/2022
2	Adenocarcinoma of Lung 06/2022 - 12/2020
2	Liver Neoplasms (Liver Cancer) 11/2021 - 01/2015
2	Infections 01/2021 - 09/2016
2	Hyperplasia 01/2021 - 11/2014
2	Nasopharyngeal Carcinoma 01/2019 - 10/2015
2	Breast Neoplasms (Breast Cancer) 01/2015 - 06/2013
2	Cysts 01/2014 - 07/2013
1	Hypothyroidism 04/2024
1	Hematologic Neoplasms (Hematological Malignancy) 03/2024
1	Brain Neoplasms (Brain Tumor) 02/2024
1	Liver Diseases (Liver Disease) 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Reperfusion Injury 01/2023
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023
1	Stroke (Strokes) 11/2022
1	Cholangiocarcinoma 08/2022
1	Primary Ovarian Insufficiency 01/2022
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022
1	Microsatellite Instability 04/2021
1	Adenocarcinoma 04/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Neuroblastoma 01/2021

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2010
5	Tyrosine Kinase InhibitorsIBA 02/2024 - 12/2020
5	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2019
4	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 04/2015
4	Lamin Type B (Lamin B)IBA 01/2016 - 01/2014
3	Transcription Factors (Transcription Factor)IBA 12/2023 - 01/2010
3	ErbB Receptors (EGF Receptor)IBA 01/2023 - 06/2022
2	Phosphotransferases (Kinase)IBA 03/2024 - 06/2022
2	CurcuminIBA 12/2023 - 01/2021
2	Dextran SulfateIBA 01/2023 - 01/2020
2	AnisomycinIBA 01/2023 - 01/2022
2	ChromatinIBA 01/2022 - 11/2021
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 12/2020
2	RNA (Ribonucleic Acid)IBA 11/2021 - 04/2015
2	NF-kappa B (NF-kB)IBA 01/2021 - 01/2010
2	Messenger RNA (mRNA)IBA 01/2021 - 06/2013
2	Cadherins (E-Cadherin)IBA 01/2019 - 12/2015
2	LaminsIBA 01/2016 - 07/2013
2	Glucose (Dextrose)FDA LinkGeneric 08/2013 - 01/2013
1	Neurotransmitter Agents (Neurotransmitter)IBA 04/2024
1	sintilimabIBA 04/2024
1	anlotinibIBA 04/2024
1	MB Form Creatine KinaseIBA 04/2024
1	PlatinumIBA 04/2024
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 04/2024
1	neurotrophin 4IBA 03/2024
1	TropomyosinIBA 03/2024
1	LigandsIBA 03/2024
1	trkB ReceptorIBA 03/2024
1	Chimeric Antigen ReceptorsIBA 03/2024
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2024
1	Bevacizumab (Avastin)FDA Link 02/2024
1	ArsenicIBA 12/2023
1	FlavonoidsIBA 01/2023
1	guhongIBA 01/2023
1	JNK Mitogen-Activated Protein KinasesIBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Silybin (Lagosa)IBA 01/2023
1	Tyrosine (L-Tyrosine)FDA Link 06/2022
1	Thioctic Acid (Lipoic Acid)IBA 01/2022
1	YY1 Transcription FactorIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 11/2021
1	Long Noncoding RNAIBA 11/2021
1	Competitive Endogenous RNAIBA 11/2021
1	Calcibiotic Root Canal SealerIBA 04/2021
1	thiazolyl blueIBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Polysaccharides (Glycans)IBA 01/2021
1	Mitogen-Activated Protein KinasesIBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	CrizotinibIBA 01/2021
1	mitogen and stress-activated protein kinase 1IBA 01/2021
1	1- (diethylaminopropyl)- 4- phenylpiperazineIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Taurine FDA Link 01/2021
1	Anaplastic Lymphoma KinaseIBA 12/2020

Therapy/Procedure

12	Therapeutics 04/2024 - 01/2015
5	Drug Therapy (Chemotherapy) 04/2024 - 01/2019
4	Radiotherapy 05/2024 - 10/2015
3	Immunotherapy 01/2023 - 04/2021
2	Transplantation 01/2023 - 01/2022
2	Chemoradiotherapy 01/2022 - 01/2019
2	Neoadjuvant Therapy 01/2022 - 10/2020
1	Molecular Targeted Therapy 01/2023
1	Ligation 01/2023